# Common Sensing

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/common-sensing

- Industry: Medical Devices & Equipment
- Headquarters: Cambridge, US
- Website: www.common-sensing.com
- Latest round: Series A (Mar 15, 2018)
- Investors on record: 4

## About

Common Sensing Inc. specializes in developing innovative diabetes management solutions, focusing on seamless technology integration for better health outcomes.Founded in 2012 in Cambridge, US, Common Sensing Inc. creates advanced diabetes management devices and software. The company has undergone strategic pivots to enhance its product offerings. Co-founded by James White, Jamie White, and Richard Whalley, it has raised a total of USD 0.20 mn through 7 deals, with the latest funding round being VENTURE DEBT in April 2019, amounting to USD 2.00 mn. The current CEO is Kevin Schmid.Common Sensing Inc. provides a range of diabetes management solutions that integrate hardware and software to simplify tracking glucose levels. Their primary product includes smart insulin delivery systems designed to enhance user engagement and adherence to diabetes care protocols, particularly targeting users in regions where diabetes management technologies are increasingly sought after.Common Sensing Inc. generates revenue through sales of its diabetes management devices and associated software services. Revenue is derived from direct sales to consumers, including healthcare providers and pharmacies, as well as partnerships with healthcare organizations to facilitate user access to their innovative solutions.In April 2019, Common Sensing Inc. secured USD 2.002 million in VENTURE DEBT funding, which will support the development of new diabetes management products and expand market presence. The company plans to launch a new line of smart devices by the end of 2023 and aims to enter additional markets, particularly in Europe and Asia, by 2024, to meet the growing demand for comprehensive diabetes care solutions.

## Funding rounds

- Series A, Mar 15, 2018 — Royal Philips, Waterline Ventures, Wilhelm Haselmeier GmbH & Co., New World Health

## Investors

- Royal Philips — Series A
- Waterline Ventures (https://capitalatlas.ai/funds/waterline-ventures) — Series A
- Wilhelm Haselmeier GmbH & Co. — Series A
- New World Health (https://capitalatlas.ai/funds/new-world-health) — Series A